Signum Morning Briefing: Join us on 3 December and explore how evolving data landscapes – from new sources to smarter sharing – are shaping the future of patient outcomes and commercial pharma strategy.

X

Sign up for Signum Morning Briefing

Evolving data landscapes in pharma

Join us for the final Signum Morning Briefing of 2025, where we explore how evolving data landscapes – from new sources to smarter sharing – are shaping the future of patient outcomes and commercial pharma strategy. Discover the essential insights delivered by Real-World Evidence studies this year and engage in meaningful discussions with our expert speakers and peers from across the life science community. 

N.B. The event is in English, but you’re welcome to ask questions in Danish. See the complete program below*.

Date

December 3rd, 2025

Time

8:30 – 10:30 (The presentations start at 9 am, but there will be breakfast and networking from 8:30 am)

Place

Life Science House, Lersø Parkallé 101, Copenhagen

Program


08:30 Networking and breakfast
09:00 Welcome

Søren-Ulrik Rolsted Fangholm, Chief Operating Officer, LIF Group & Nordic General Manager, Signum Life Science

09:10 How patient-generated data is reshaping RWE

Speaker TBA

09:30 Real-World questions, Real-World answers: RWE in pharma practice in 2025

See how Nordic pharma companies are using Real-World Evidence to address specific business challenges. Our team presents case studies from recent client work, demonstrating practical applications of RWE in supporting product launches, HTA submissions, and understanding treatment patterns.

Anne Cathrine Falch-Jørgensen, Head of Real-World Evidence Nordics, Signum Life Science

09:50 Group discussion

Discuss the RWE cases you just saw with others at your table. Share your reactions, consider how these approaches could work in your organization, and ask questions to the speakers.

10:00 The future of health data access in Denmark

Denmark is establishing a centralized hub for accessing health data. Learn how this connects with the European Health Data Space and how a single national point of access can open new opportunities for faster, data-driven innovation and help bring better treatments to patients more efficiently.

Thomas Klit Christensen, Head of Foreign Trade at Lif, The Danish Association of the Pharmaceutical Industry

10:20 Closing remarks

Søren-Ulrik Rolsted Fangholm, Chief Operating Officer, LIF Group & Nordic General Manager, Signum Life Science

N.B. We will take pictures and record the event for marketing purposes. Please get in touch with a Signum team member on the day if you prefer not to appear in them.

The program is subject to change. Please note that we reserve the right to review and decline registrations if necessary.

Get in touch


Leave a message and we will get back to you ASAP.
Your personal information will be processed according to our Privacy Policy.